NASDAQ:LENZ | Free Cash Flow | LENZ Therapeutics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2020-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$33.58M$18,000.00-$33.6M
2025-12-31-$33.03M$38,000.00-$33.06M
2025-03-31-$16.05M$110,000.00-$16.16M
2024-12-31-$9.08M$149,000.00-$9.23M
2024-03-31-$23.94M$0.00-$23.94M
2023-12-31-$20.97M$0.00-$20.97M
2023-03-31-$12.8M$6,000.00-$12.8M
2022-12-31-$22.43M$1.02M-$23.45M
2022-03-31-$21.24M$3.27M-$24.51M
2021-12-31-$15.59M$981,000.00-$16.57M
2021-03-31-$8.06M$360,000.00-$8.42M
2020-12-31-$5.27M$612,000.00-$5.88M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$69.17M$827,000.00-$70M
2024-12-31-$59.39M$468,000.00-$59.86M
2023-12-31-$60.38M$30,000.00-$60.41M
2022-12-31-$87.98M$6.59M-$94.57M
2021-12-31-$52.85M$5.74M-$58.59M
2020-12-31-$8.72M$1.55M-$10.27M